Research Figures
Data from the Scientific Report 2022
- 489 Projects
- 355 Clinical Trials
- 802 Publications
- 6332 Total Impact Factor
News
A drug capable of simultaneously targeting three different therapeutic targets is designed.
The study, published in the journal Bioorganic Chemistry, presents a proof of concept for this innovative triple-effect compound, which has been successfully applied to breast cancer cells. According to experts, this therapy has "high potential for the treatment of complex diseases such as cancer or diabetes.
Researchers discover a new promising strategy to halt the progression of liver fibrosis
The new work, published in the journal Biomedicine & Pharmacotherapy, has been led by Manuel Vázquez Carrera, head of the research group Pharmacological Targets in Inflammation and Metabolic Diseases at the Sant Joan de Déu Research Institute (IRSJD) and the Biomedical Research Centre in Diabetes and Associated Metabolic Diseases (CIBERDEM) at the University of Barcelona.
Interviews
César Galo Garcia Fontecha
Head of the Orthopaedic Surgery and Traumatology Group
“Learning about what others are doing allows us to improve and develop new ideas in order to advance in the world of research.”
Read more More Interviews
Agenda
Patient Involvement in research projects
The Fundació de Recerca Sant Joan de Déu · Institut de Recerca Sant Joan de Déu is organizing its 1rst conference on patient involvement in research projects.
i4KIDS | Pediatric Innovation Day Barcelona
Join us at the Pediatric Innovation Day in Barcelona! Discover cutting-edge advancements in paediatric healthcare and meet global experts.